Kristoffer Staal Rohrberg

17PUBLICATIONS

204CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targetsHaematological tumoursCellular immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 19, 2026

First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|Apr 07, 2026

A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Mar 09, 2026

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Changhoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin

|Feb 12, 2026

Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform.

Silje Kjølle, Mario Presti, Jéssica de Pina Roque

|Jan 07, 2026

Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Henk Van der Pol, Tina Kringelbach, Maria Martin Agudo

|Oct 30, 2025

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.

Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem

Pageof 3

Frequent Collaborators

Ulrik Lassen

Ignacio Melero

Victor Moreno

Emiliano Calvo

Josep Tabernero

Christophe Boetsch

Neeltje Steeghs

Iakov I Davydov

Iben Spanggaard

Tamara Tanos

Frequent Collaborators

Ulrik Lassen

Ignacio Melero

Victor Moreno

Emiliano Calvo